Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Change in Account Payables (2018 - 2025)

Historic Change in Account Payables for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to -$831000.0.

  • Viemed Healthcare's Change in Account Payables fell 12643.05% to -$831000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $379000.0, marking a year-over-year increase of 16503.5%. This contributed to the annual value of $359000.0 for FY2024, which is 14179.28% up from last year.
  • Viemed Healthcare's Change in Account Payables amounted to -$831000.0 in Q3 2025, which was down 12643.05% from $422000.0 recorded in Q2 2025.
  • In the past 5 years, Viemed Healthcare's Change in Account Payables registered a high of $2.3 million during Q3 2021, and its lowest value of -$2.5 million during Q4 2021.
  • For the 5-year period, Viemed Healthcare's Change in Account Payables averaged around $4315.8, with its median value being $224000.0 (2022).
  • Per our database at Business Quant, Viemed Healthcare's Change in Account Payables surged by 39473.68% in 2022 and then plummeted by 60401.79% in 2023.
  • Viemed Healthcare's Change in Account Payables (Quarter) stood at -$2.5 million in 2021, then soared by 85.99% to -$351000.0 in 2022, then tumbled by 72.08% to -$604000.0 in 2023, then skyrocketed by 35.76% to -$388000.0 in 2024, then tumbled by 114.18% to -$831000.0 in 2025.
  • Its Change in Account Payables was -$831000.0 in Q3 2025, compared to $422000.0 in Q2 2025 and $1.2 million in Q1 2025.